Workflow
Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference
ArdelyxArdelyx(US:ARDX) GlobeNewswire News Room·2025-02-19 13:01

Company Overview - Ardelyx, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative, first-in-class medicines to address significant unmet medical needs [3] - The company has two commercial products approved in the United States: IBSRELA® (tenapanor) and XPHOZAH® (tenapanor) [3] - Ardelyx has international agreements for the development and commercialization of tenapanor, including partnerships with Kyowa Kirin in Japan and Fosun Pharma in China [3] Upcoming Events - Management will present at TD Cowen's 45th Annual Health Care Conference on March 3, 2025, at 9:50 am ET in Boston [1] - A live webcast of the presentation will be available on the Ardelyx website, with a replay accessible for 30 days post-event [2]